Schonfeld Strategic Advisors LLC

Position in BDTX — Black Diamond Therapeutics, Inc.

CIK 1665241 NEW YORK, NY

Position in BDTX

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$39,988

-$188,122 QoQ

Shares Held

18,774

-76.9% QoQ

Ownership

0.033%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2020

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

Schonfeld Strategic Advisors LLC holds $295,904,773 across 126 Biotechnology names. BDTX ranks #115 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	FOLD	AMICUS THERAPEUTICS, INC.	1,757,899	$25,419,219
2	ALNY	Alnylam Pharmaceuticals, Inc.	71,767	$23,745,547
3	PTCT	Ptc Therapeutics, Inc.	318,405	$21,692,932
4	XENE	Xenon Pharmaceuticals Inc.	324,722	$18,882,584
5	INBX	Inhibrx Biosciences, Inc.	254,827	$17,132,019
6	JAZZ	Jazz Pharmaceuticals plc	62,142	$11,747,945
7	RARE	Ultragenyx Pharmaceutical Inc.	494,737	$10,364,740
8	INSM	INSMED Inc	56,056	$9,166,277

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$39,988	18,774	-76.9%	Shares	Sole	2026-05-15
2023-12-31	$228,110	81,178	-45.6%	Shares	Sole	2024-02-14
2023-09-30	$427,917	149,100	+965.0%	Shares	Sole	2023-11-14
2022-09-30	$23,660	14,000	-5.4%	Shares	Sole	2022-11-14
2022-06-30	$36,408	14,800	-25.6%	Shares	Sole	2022-08-15
2022-03-31	$55,123	19,900	+35.4%	Shares	Sole	2022-05-16
2021-12-31	$78,351	14,700	-1.3%	Shares	Sole	2022-02-14
2021-09-30	$126,054	14,900	-47.7%	Shares	Sole	2021-11-16
2021-06-30	$347,415	28,500	-14.4%	Shares	Sole	2021-11-16
2020-12-31	$1,067,681	33,313	+311.3%	Shares	Sole	2021-02-16
2020-09-30	$244,863	8,100	—	Shares	Sole	2020-11-19
No filing history on record for this holder in this stock.